State Of Wyoming Nuvation Bio Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.24 - $5.85 $4,600 - $8,307	-1,420 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.6 - $8.83 $1,467 - $2,816	319 Added 28.97%	1,420 $7,000
Q4 2021 Feb 11, 2022	BUY	$7.75 - $10.05 $1,658 - $2,150	214 Added 24.13%	1,101 $9,000
Q3 2021 Feb 11, 2022	SELL	$7.78 - $10.0 $3,913 - $5,030	-503 Reduced 36.19%	887 $9,000
Q2 2021 Feb 11, 2022	BUY	$9.22 - $14.48 $12,815 - $20,127	1,390 New	1,390 $13,000

126

107M

40.6K

2.9K

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $634M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.